Anti-measles vaccination by aerosol in Mexico;La vacunacion antisarampionosa en Mexico por el metodo de aerosol

Salud Publica de Mexico

Volumn 39, Issue 1, 1997, Pages 53-60

  Castro, Jorge Fernández De ^a,e   Kumate Rodríguez, Jesús ^b   Sepúlveda, Jaime ^c   Ramírez Isunza, José Manuel ^d   Valdespino Gómez, José Luis ^c  

^a SECRETARÍA DE SALUD   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d HOSPITAL GENERAL DE MÉXICO   (Mexico)

^e INSP ^*  (Mexico)

Author keywords

aerosol; Edmonston Zagreb vaccine; mass vaccination; measles vaccine; Mexico

Indexed keywords

MEASLES VACCINE;

ARTICLE; CHILD; DRUG EFFICACY; DRUG SAFETY; HEALTH PROGRAM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MEASLES; MEDICAL EDUCATION; MEXICO; VACCINATION;

EID: 0010979565     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. World Health Organization. Global Programme for Vaccines and Immunization. Programme Report 1995. Ginebra: World Health Organization, 1996.
2. Anderson RM. Directly transmitted infectious disease: Control by vaccination Science 1982;215:1053-1060.
3. Fernández de Castro J, Kumate J. La vacunación contra el sarampión. Situation en México y en América. Avances en el método de inmunización por aerosol. Bol Med Hosp Infant Mex 1990;47(7):449-461.
4. Sabin AB, Flores-Aréchiga A, Fernández-de Castro J, Sever JL, Madden DL, Shekarchi I et al. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chicken embryo fibroblast vaccines. JAMA 1983;249:2651-2662.
5. Sabin AB, Flores-Aréchiga A, Fernández-de Castro J, Albrecht P, Sever JL, Shekarchi I. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II.Vaccine comparisons and evidence for multiple antibody response. JAMA 1984;251:2363-2371.
6. Fernández-de Castro J,Valdespino JL, Díaz-Ortega JL, Zárate ML. Diploid cell measles vaccine. JAMA 1986;256(8):714.
7. Markowitz L, Sepúlveda J, Díaz-Ortega JL, Valdespino JL, Albrecht P, Zell E et al. Immunization on six-month-old infants with different doses of Edmonston-Zagreb and schwarz measles vaccines. N Engl J Med 1990;322(9):580-587.
8. Diaz-Ortega JL, Luna-Abascal M,Valdespino JL, Sepúlveda J, Markowitz L, Zell E. Mortality and morbidity after high titer measles vaccine in México Lancet 1992;340:924.
9. Albrecht P, Hormann K, Burns GR. Role of virus strain in convectional and enhanced measles plaque neutralization test. J Virol Methods 1981;3:251-260
10. Fernández-Bracho JG, Roldán-Fernández SG. Reacciones tempranas en escolares vacunados con antisarampionosa en aerosol. Salud Publica Mex 1990;32(6):653-656.
11. Expanded Programme in Immunization. Measles Elimination in the Americas. Bull Pan Am Health Organ 1992;26:271-272
12. Tidjani O, Grunitsky B, Guérin N, Lévy-Bruh ID, Lecam N, Xuereff C et al. Serological effects of Edmonston Zagreb, Schwarz and AIK-C Measles vaccines strains given at ages 4-5 or 8-10 months. Lancet 1989;2(8676): 1357-1360.
13. Whittle HC, Mann G, Eccles MO, Neill K, Jupp L, Hanion P et al Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months. Lancet 1988;1(8592):963-969.
14. Garenne M, Leroy O, Beau JP, Sene I. Child mortality after high-titer measles vaccines: Prospective study in Senegal. Lancet 1991;ii:9903-9907.
15. Expanded Programme In Immunization. Safety and efficacy of high titer measles vaccine at 6 months of age.Wkly Epidemiol Rec 1991;66:249-251.
16. Markowitz L, Orenstein W. Measles vaccines. Pediatr Clin North Am 1990;37:603-625.